These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 27251479)
21. [Non-metastatic oesophageal cancer: diagnosis and treatment]. Voeten DM; den Bakker CM; Goedegebuure RSA; Heineman DJ; Daams F; van der Peet DL Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556490 [TBL] [Abstract][Full Text] [Related]
22. [Preoperative radiochemotherapy of esophageal carcinoma. Light at the end of the tunnel?]. Hölscher AH; Metzger R; Schneider PM Zentralbl Chir; 2000; 125(4):319-25. PubMed ID: 10829311 [TBL] [Abstract][Full Text] [Related]
23. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. Bates BA; Detterbeck FC; Bernard SA; Qaqish BF; Tepper JE J Clin Oncol; 1996 Jan; 14(1):156-63. PubMed ID: 8558191 [TBL] [Abstract][Full Text] [Related]
24. Early detection and management of esophageal cancer. Margulies C; Kim R; Reynolds JC Compr Ther; 1996 Sep; 22(9):565-78. PubMed ID: 8902348 [No Abstract] [Full Text] [Related]
26. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery. Reisinger KW; Bosmans JW; Uittenbogaart M; Alsoumali A; Poeze M; Sosef MN; Derikx JP Ann Surg Oncol; 2015 Dec; 22(13):4445-52. PubMed ID: 25893413 [TBL] [Abstract][Full Text] [Related]
27. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952 [TBL] [Abstract][Full Text] [Related]
28. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma. Chao YK; Yeh CJ; Chang HK; Tseng CK; Chu YY; Hsieh MJ; Wu YC; Liu HP Ann Surg Oncol; 2011 Feb; 18(2):529-34. PubMed ID: 20697822 [TBL] [Abstract][Full Text] [Related]
32. Does neoadjuvant treatment before oncologic esophagectomy affect the postoperative quality of life? A prospective, longitudinal outcome study. Hauser C; Patett C; von Schoenfels W; Heits N; Schafmayer C; Malchow B; Hampe J; Schniewind B; Becker T; Egberts JH Dis Esophagus; 2015 Oct; 28(7):652-9. PubMed ID: 25059631 [TBL] [Abstract][Full Text] [Related]
33. New therapeutic strategies for squamous cell cancer and adenocarcinoma. Wijnhoven BPL; Toxopeus ELA; Vallböhmer D; Knoefel WT; Krasna MJ; Perez K; van Rossum PSN; Ruurda JP; van Hillegersberg R; Schiesser M; Schneider P; Felix VN Ann N Y Acad Sci; 2013 Oct; 1300():213-225. PubMed ID: 24117644 [TBL] [Abstract][Full Text] [Related]
34. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy. Chidel MA; Rice TW; Adelstein DJ; Kupelian PA; Suh JH; Becker M Radiology; 1999 Oct; 213(1):67-72. PubMed ID: 10540642 [TBL] [Abstract][Full Text] [Related]
35. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus. Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492 [TBL] [Abstract][Full Text] [Related]
36. [Long-term outcome of neoadjuvant radiochemotherapy followed by surgery for esophageal cancer: a single institution retrospective study of 102 patients]. Ruffier-Loubière A; Janoray G; Chapet S; de Calan L; Dumont P; Dorval É; Orain I; Calais G Cancer Radiother; 2015 Aug; 19(5):322-30. PubMed ID: 26215366 [TBL] [Abstract][Full Text] [Related]
37. Management of esophageal carcinoma. Perlmutter AE; Karimi KM; McFadden DW; Nigam A W V Med J; 2005; 101(2):60-3. PubMed ID: 16042088 [TBL] [Abstract][Full Text] [Related]
38. Longitudinal analysis of cytokine expression during neoadjuvant chemoradiotherapy and subsequent surgery in esophageal cancer patients. Bosch DJ; Wang D; Nijsten MW; Mul VE; Hospers GA; Burgerhof JG; Struys MM; Plukker JT Am J Surg; 2016 Jul; 212(1):89-95. PubMed ID: 27036621 [TBL] [Abstract][Full Text] [Related]
39. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463 [TBL] [Abstract][Full Text] [Related]
40. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]